Awarded
Provision of SCID Screening Assay Kits
£310,000
NHS EnglandRevvity (UK) Limited
services
Contract Details
- Tender Value
- £310,000
- Stage
- Awarded
- Published
- Awarded
Timeline
Start
Awarded
Disclosed
End
Description
A call off under National Microbiology Framework for the EONIS Q Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in Screening laboratories to Revvity.
Related Contracts
From This Buyer
From This Supplier
In This Category
Ref: 7ee11c14-1da6-4e37-8db5-2c7b418c9f1d-856553 · Sourced from Contracts Finder
View source notice